Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
a1NEL2G7EmV0Ar7h